论文部分内容阅读
有关PCE/NCE比值的正常范围问题在保健食品的安全性审评中一直存在争议。就骨髓微核试验中的PCE/NCE比值的概念、正常范围等问题进行了讨论,并对国标GB15193.05及《保健食品检验与评价技术规范》的修订提出了相关的建议。
The question of the normal range of PCE / NCE ratios has been controversial in the safety review of health foods. The concept of PCE / NCE ratio in bone marrow micronucleus test, the normal range and other issues were discussed. Relevant suggestions were made for the revision of GB15193.05 and the revision of “Technical Specification for Testing and Evaluation of Health Food”.